AHR and inflammatory bowel disease: I3C and its condensation products have potential effects in treating inflammatory bowel diseases by modulating the differentiation and function of T cells (Treg cells) through AhR activation, while reducing the number of helper T cells (Th cells) to alleviate intestinal inflammation (Rouse et al., 2013).